India's Paras moves into target
This article was originally published in Scrip
Executive Summary
Paras Pharmaceuticals, the Indian OTC and personal care products firm, has emerged as target for acquisition. Potential acquirers include multinationals GlaxoSmithKline and Sanofi-Aventis and a number of local companies.